ANURAS2021-10-012021-12-31in-bse-fin:OneOperatingExpenses01Member ANURAS2021-10-012021-12-31in-bse-fin:FourOperatingExpenses01Member ANURAS2021-10-012021-12-31in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member ANURAS2021-10-012021-12-31in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss02Member ANURAS2021-10-012021-12-31in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss01Member ANURAS2021-10-012021-12-31in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss02Member ANURAS2021-10-012021-12-31in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss01Member ANURAS2021-10-012021-12-31in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss02Member ANURAS2021-10-012021-12-31in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss01Member ANURAS2021-10-012021-12-31in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss02Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares ANURAS 2021-04-01 2022-03-31 2022-02-05 INR Millions Third quarter Single segment The Company operates only in the one revenue segment. i.e. Manufacturing of industrial chemicals. 2021-10-01 2021-12-31 Unaudited Standalone 2661616000.00 49607000.00 2711223000.00 1664108000.00 0.00 -764392000.00 122798000.00 52304000.00 154948000.00 886185000.00 2115951000.00 595272000.00 0.00 595272000.00 95883000.00 120562000.00 216445000.00 0.00 378827000.00 0.00 0.00 0.00 0.00 378827000.00 739000.00 379566000.00 379566000.00 0.00 999224000.00 10 3.79 3.78 0.00 0.00 3.79 3.78 [1] The above standalone financial results for the quarter and nine months ended December 31,2021 have been prepared by the Company in accordance with Regulation 33 of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 (as amended) and were reviewed by the Audit Committee of the Board of Directors of the Company and thereafter were approved and taken on record by the Board of Directors in their meeting held on 11th February, 2022. An interim review of the above results has been carried out by the statutory auditors of the Company. [2] Based on the management approach as defined in Ind AS 108 - Operating Segments, the Chief Operating Decision Maker (CODM) evaluates the company's performance and allocates resources based on an analysis of various performance indicators of business segment/s in which the company operates. The Company is primarily engaged in the business of custom synthesis and manufacturing of specialty chemicals which the management and CODM recognise as the sole business segment. Hence, disclosure of segment-wise information is not required and accordingly not provided. [3] The Company has taken into account the potential impacts of Covid-19 in the preparation of Standalone Financial Results . Based on the information currently available there is no material impact on the carrying amount of assets and hence no provision for any impairment is required. As the situation unfolds in future, the eventful impact may be different from the estimates made as on the date of approval of these Standalone Financial Results. [4] The figures of the previous period have been re-grouped / rearranged and / or recasted wherever considered necessary. Single segment 2021-04-01 2021-12-31 Unaudited Standalone 7487666000.00 154857000.00 7642523000.00 4821821000.00 0.00 -2142034000.00 359174000.00 170574000.00 446883000.00 2457460000.00 6113878000.00 1528645000.00 0.00 1528645000.00 273337000.00 198427000.00 471764000.00 0.00 1056881000.00 0.00 0.00 0.00 0.00 1056881000.00 -10846000.00 1046035000.00 1046035000.00 0.00 999224000.00 10 10.58 10.54 0.00 0.00 10.58 10.54 Other Expenses 886185000.00 Other Expenses 2457460000.00